JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

Search

ResMed Inc

Geschlossen

BrancheGesundheitswesen

262.42 4.55

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

251.38

Max

264.55

Schlüsselkennzahlen

By Trading Economics

Einkommen

-31M

349M

Verkäufe

-12M

1.3B

KGV

Branchendurchschnitt

26.175

90.422

Dividendenrendite

0.87

Gewinnspanne

26.096

Angestellte

10,600

EBITDA

-29M

503M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+18.02% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.87%

2.13%

Nächstes Ergebnis

22. Apr. 2026

Nächste Dividendenausschüttung

19. März 2026

Nächstes Ex-Dividendendatum

12. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-539M

37B

Vorheriger Eröffnungskurs

257.87

Vorheriger Schlusskurs

262.42

Nachrichtenstimmung

By Acuity

9%

91%

8 / 352 Ranking in Healthcare

ResMed Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Feb. 2026, 23:11 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3. Feb. 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. Feb. 2026, 23:50 UTC

Market Talk

Nikkei May Decline After Hitting All-Time High -- Market Talk

3. Feb. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

3. Feb. 2026, 23:41 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3. Feb. 2026, 23:38 UTC

Ergebnisse

AMD Sales Climb on Help From Data-Center Business -- Update

3. Feb. 2026, 23:29 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3. Feb. 2026, 23:27 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3. Feb. 2026, 23:25 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3. Feb. 2026, 23:23 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3. Feb. 2026, 23:22 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3. Feb. 2026, 23:19 UTC

Market Talk

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3. Feb. 2026, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

3. Feb. 2026, 22:56 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3. Feb. 2026, 22:40 UTC

Ergebnisse

Amdocs Extends Collaboration With T-Mobile

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q Adj EPS $1.81

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q Rev $1.16B

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q EPS $1.45 >

3. Feb. 2026, 22:38 UTC

Ergebnisse

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3. Feb. 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3. Feb. 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3. Feb. 2026, 22:14 UTC

Ergebnisse

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3. Feb. 2026, 22:13 UTC

Ergebnisse

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3. Feb. 2026, 22:12 UTC

Ergebnisse

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3. Feb. 2026, 22:10 UTC

Ergebnisse

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3. Feb. 2026, 22:10 UTC

Ergebnisse

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3. Feb. 2026, 22:10 UTC

Market Talk

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3. Feb. 2026, 22:10 UTC

Ergebnisse

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3. Feb. 2026, 22:09 UTC

Ergebnisse

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3. Feb. 2026, 22:09 UTC

Ergebnisse

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Peer-Vergleich

Kursveränderung

ResMed Inc Prognose

Kursziel

By TipRanks

18.02% Vorteil

12-Monats-Prognose

Durchschnitt 300.64 USD  18.02%

Hoch 345 USD

Tief 265 USD

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ResMed Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

13 ratings

8

Buy

5

Halten

0

Sell

Stimmung

By Acuity

8 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat